Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Correvio Pharma Corp (TSX: CORV )

0.5600 CAD UNCHANGED
Last Price Updated: 3:32 PM EDT, May 29, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Correvio Pharma Corp

< Previous 1 2 3 4 Next >
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Correvio Pharma Corp. common stock - CORV
The Rosen Law Firm, P.A. announces that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action settlement that would... 
From PR Newswire
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
From PR Newswire
Correvio Obtains Final Order for Plan of Arrangement
From PR Newswire
Correvio Announces Results from Annual General and Special Meeting of Securityholders
From PR Newswire
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
From PR Newswire
Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
From PR Newswire
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
From PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?
Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration,... 
From PR Newswire
Correvio Pharma Corp. (NASDAQ: CORV) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 04/17/2020 -- 
From SBWire - Latest Press Releases
Correvio Obtains Interim Order For Plan Of Arrangement
From PR Newswire
Correvio Reports Full Year 2019 Financial Results
From PR Newswire
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – CORV, TERP, IOTS, CBB
From GlobeNewswire News Releases
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Correvio Pharma Corp. (NasdaqGS: CORV) to... 
From Business Wire News Releases
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH, CORV
From ACCESSWIRE
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
From PR Newswire
ADVANZ PHARMA to Acquire Correvio
From PR Newswire
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China
From PR Newswire
Correvio Responds to Market Activity
From PR Newswire
NASDAQ: CORV Investor Notice: Deadline on Feb. 10th Coming Up in Lawsuit for Investors in Correvio Pharma Corp.
San Diego, CA -- (SBWIRE) -- 02/10/2020 -- A Deadline is coming up on February 10, 2020 in the lawsuit for certain investors in Correvio Pharma Corp. (NASDAQ: CORV) and NASDAQ: CORV stockholders should... 
From SBWire - Latest Press Releases
INVESTOR ALERT - Correvio Pharma Corp. (CORV) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020
From GlobeNewswire News Releases
CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline – CORV
From GlobeNewswire News Releases
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
From GlobeNewswire News Releases
DEADLINE ALERT for CTAS, CORV, GDOT, OPRA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
INVESTOR ALERT - Correvio Pharma Corp. (CORV) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020
From GlobeNewswire News Releases
CORREVIO DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm
From GlobeNewswire News Releases
COR DEADLINE: Pawar Law Group Reminds Investors of February 10 Deadline in Securities Class Action Lawsuit Against Correvio Pharma Corp.– CORV
From GlobeNewswire News Releases
CORV NOTICE: ROSEN, A LEADING LAW FIRM, Reminds Correvio Pharma Corp. Investors of Important February 10th Deadline in Securities Class Action – CORV
From GlobeNewswire News Releases
CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role... 
From Business Wire News Releases
NASDAQ: CORV Investor Alert: Lawsuit Alleges Securities Laws Violations by Correvio Pharma Corp.
San Diego, CA -- (SBWIRE) -- 01/31/2020 -- A lawsuit was filed on behalf of investors in Correvio Pharma Corp. (NASDAQ: CORV) shares over alleged securities laws violations. 
From SBWire - Latest Press Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.